关注
Benoit Arsenault
Benoit Arsenault
在 criucpq.ulaval.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity
R Ross, IJ Neeland, S Yamashita, I Shai, J Seidell, P Magni, RD Santos, ...
Nature Reviews Endocrinology 16 (3), 177-189, 2020
13342020
Association of LDL cholesterol, non–HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
SM Boekholdt, BJ Arsenault, S Mora, TR Pedersen, JC LaRosa, PJ Nestel, ...
Jama 307 (12), 1302-1309, 2012
10172012
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
IJ Neeland, R Ross, JP Després, Y Matsuzawa, S Yamashita, I Shai, ...
The lancet Diabetes & endocrinology 7 (9), 715-725, 2019
8932019
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
SM Boekholdt, GK Hovingh, S Mora, BJ Arsenault, P Amarenco, ...
Journal of the American College of Cardiology 64 (5), 485-494, 2014
8152014
Lipoprotein (a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
F Kronenberg, S Mora, ESG Stroes, BA Ference, BJ Arsenault, L Berglund, ...
European heart journal 43 (39), 3925-3946, 2022
4932022
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials
DD Waters, JE Ho, DA DeMicco, A Breazna, BJ Arsenault, CC Wun, ...
Journal of the American College of Cardiology 57 (14), 1535-1545, 2011
4862011
Precision nutrition: a review of personalized nutritional approaches for the prevention and management of metabolic syndrome
J de Toro-Martín, BJ Arsenault, JP Després, MC Vohl
Nutrients 9 (8), 913, 2017
4182017
Oxidized phospholipids, lipoprotein (a), and progression of calcific aortic valve stenosis
R Capoulade, KL Chan, C Yeang, P Mathieu, Y Bossé, JG Dumesnil, ...
Journal of the American College of Cardiology 66 (11), 1236-1246, 2015
4072015
Beyond low-density lipoprotein cholesterol: respective contributions of non–high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density …
BJ Arsenault, JS Rana, ESG Stroes, JP Després, PK Shah, JJP Kastelein, ...
Journal of the American College of Cardiology 55 (1), 35-41, 2009
3962009
Lipoprotein (a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case–control cohort
BJ Arsenault, SM Boekholdt, MP Dubé, É Rhéaume, NJ Wareham, ...
Circulation: Cardiovascular Genetics 7 (3), 304-310, 2014
3052014
High-density lipoprotein particle size and concentration and coronary risk
K El Harchaoui, BJ Arsenault, R Franssen, JP Després, GK Hovingh, ...
Annals of internal medicine 150 (2), 84-93, 2009
2982009
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
I Postmus, S Trompet, HA Deshmukh, MR Barnes, X Li, HR Warren, ...
Nature communications 5 (1), 5068, 2014
2822014
Lipid parameters for measuring risk of cardiovascular disease
BJ Arsenault, SM Boekholdt, JJP Kastelein
Nature Reviews Cardiology 8 (4), 197-206, 2011
2742011
Lipoprotein (a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis
KH Zheng, S Tsimikas, T Pawade, J Kroon, WSA Jenkins, MK Doris, ...
Journal of the American College of Cardiology 73 (17), 2150-2162, 2019
2562019
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study
BJ Arsenault, I Lemieux, JP Després, NJ Wareham, JJP Kastelein, ...
Cmaj 182 (13), 1427-1432, 2010
2472010
Autotaxin derived from lipoprotein (a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve
R Bouchareb, A Mahmut, MJ Nsaibia, MC Boulanger, A Dahou, JL Lépine, ...
Circulation 132 (8), 677-690, 2015
2442015
Levels and changes of HDL cholesterol and apolipoprotein AI in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
SM Boekholdt, BJ Arsenault, GK Hovingh, S Mora, TR Pedersen, ...
Circulation 128 (14), 1504-1512, 2013
2402013
Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis
D Mohty, P Pibarot, JP Després, C Côté, B Arsenault, A Cartier, P Cosnay, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (1), 187-193, 2008
2272008
Determinants of residual risk in secondary prevention patients treated with high-versus low-dose statin therapy: the Treating to New Targets (TNT) study
S Mora, NK Wenger, DA DeMicco, A Breazna, SM Boekholdt, ...
Circulation 125 (16), 1979-1987, 2012
2092012
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with …
V Di Marzo, M Cote, I Matias, I Lemieux, BJ Arsenault, A Cartier, ...
Diabetologia 52, 213-217, 2009
2032009
系统目前无法执行此操作,请稍后再试。
文章 1–20